Your patient is taking belatacept and develops posttransplant lymphoproliferative disorder (PTLD). PTLD primarily affects:

Question

Quizplus · Accepted Answer

PTLD primarily affects the lymphoid tissues, which can manifest in various parts of the body, including the nervous system. It is a significant complication associated with immunosuppressive drugs like belatacept, used to prevent organ rejection in transplant patients.

Your Patient Is Taking Belatacept and Develops Posttransplant Lymphoproliferative Disorder